ArsenalBio
PrivateLast Round
Series C
9/4/2024
Total Funding Raised
$630M
Company Overview
ArsenalBio is a biotechnology company focused on discovering, developing, and commercializing innovative immune cell therapies through a comprehensive research and development platform that creates multifunctional T-cell medicines for advanced cancer treatment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ArsenalBio Comps
Public and private peers based on sector, stage, and business model.
ArsenalBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | 9/4/2024 | ||||
| Series B | 9/6/2022 | ||||
| Series A | 10/17/2019 |
Key People
Founding team and executive leadership
ArsenalBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SoftBank Investment Advisers | Series B |
| Westlake Village Biopartners | Series C, Series B, Series A |
| Regeneron Ventures | Series C |
| Waycross Ventures | Series B |
| Parker Institute for Cancer Immunotherapy | Series B, Series A, Series C |
| SoftBank Vision Fund 2 | Series C, Series B |
| Sixth Street Partners | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 25, 2025
Company is testing CAR T-cell therapies in human trials.
- Jan 13, 2025
CEO to present at the J.P. Morgan Healthcare Conference on Jan 13, 2025.
ArsenalBio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ArsenalBio's valuation, stock price, and market status.
